A 'biomarker signature' for tolerance in transplantation
- 17 August 2010
- journal article
- review article
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 6 (10) , 606-613
Abstract
In the past decade, an explosion in the number of high-throughput tools for the measurement of different cellular products has occurred. These tools have the potential to further our understanding of human disease and this development has facilitated the identification of new biomarkers in all areas of medicine. In the field of solid organ transplantation, two different areas have developed: the use of biomarkers to predict allograft tolerance for the identification of patients who can be weaned from immunosuppressive therapy, and biomarkers for the prediction of allograft rejection, so that parenchymal damage can be prevented before it becomes irreversible. In this Review, we discuss the development of biomarkers that are indicative of transplant tolerance. Identifying patients in whom donor-specific tolerance has developed would constitute a major advance in the care of organ transplant recipients. This ability would allow the minimization or even the withdrawal of immunosuppressive therapy in selected patients, thus reducing the number of adverse effects and costs, and optimizing long-term graft outcomes. The routine clinical use of these biomarkers, once validated, would bring to the fore the possibility of personalized medicine.Keywords
This publication has 60 references indexed in Scilit:
- Development of a cross-platform biomarker signature to detect renal transplant tolerance in humansJournal of Clinical Investigation, 2010
- The personal genome—the future of personalised medicine?The Lancet, 2010
- Noninvasive diagnosis of acute rejection of renal allograftsCurrent Opinion in Organ Transplantation, 2010
- MicroRNA expression profiles predictive of human renal allograft statusProceedings of the National Academy of Sciences, 2009
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionNew England Journal of Medicine, 2008
- Applying genomics to organ transplantation medicine in both discovery and validation of biomarkersInternational Immunopharmacology, 2007
- Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft toleranceProceedings of the National Academy of Sciences, 2007
- Mass spectrometry-based proteomicsNature, 2003
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001